The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.

about

A close insight to factor VIII inhibitor in the congenital hemophilia A.The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors.

P2860

Q38883211-3120917D-5351-48F5-ACD5-6145A3831D56 Q39420691-E5E8AE90-F83E-4705-93CD-144792CB89ED

P2860

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.

Item

http://www.wikidata.org/entity/Q41210614

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.

@en

type

Item

label

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.

@en

prefLabel

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.

@en

P1476

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.

@en

P2093

Hee Young Ju

http://www.w3.org/2001/XMLSchema#string

Hye Lim Jang

http://www.w3.org/2001/XMLSchema#string

Young Shil Park

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of recombinant factor VIIa in the prophylaxis of bleeding in various surgical procedures in hemophilic patients with factor VIII and factor IX inhibitors.

Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care.

Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors.

Identifying non-responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition.

Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.

Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.

Consensus recommendations for the use of FEIBA(®) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.

Factor VIII inhibitors in hemophilia A: rationale and latest evidence

Sequential therapy with activated prothrombin complex concentrates and recombinant activated factor VII to treat unresponsive bleeding in patients with hemophilia and inhibitors: a single center experience.

Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.

P304

173-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5045/BR.2015.50.3.173

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282582553

http://www.w3.org/2001/XMLSchema#string

P698

26457285

http://www.w3.org/2001/XMLSchema#string

P921

hemophilia

P932

4595584

http://www.w3.org/2001/XMLSchema#string

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.

about

P2860

P2860

The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932